Suppr超能文献

评估海藻糖和透明质酸的治疗作用:对患者护理的意义。

Assessing the therapeutic role of trehalose and hyaluronic acid: implications for patient care.

机构信息

American Preventive Screening & Education Association (APSEA), 121 East Laurel Rd, Stratford, NJ, 08084, UK.

Department of Biology, The State University of New Jersey, Rutgers, New Brunswick, NJ, USA.

出版信息

Int Ophthalmol. 2024 Oct 1;44(1):398. doi: 10.1007/s10792-024-03308-1.

Abstract

OBJECTIVE

This Systematic review aims to assess the efficacy of trehalose and hyaluronic acid in enhancing ocular recovery post-cataract surgery, focusing on their impact on tear film stability, ocular surface integrity, and patient-reported outcomes.

METHODS

A comprehensive search was conducted across MEDLINE, PubMed, and Cochrane Library databases to identify randomized controlled trials investigating the efficacy of trehalose, hyaluronic acid, or their combination in post-cataract surgery care. The inclusion criteria focused on peer-reviewed studies in English, detailing outcomes relevant to ocular recovery such as tear film stability, ocular surface integrity, patient-reported discomfort, or visual acuity (VA). The quality of the included studies was assessed using the Cochrane Risk of Bias Tool and synthesized the data qualitatively.

RESULTS

Four qualitative investigations met the inclusion criteria. The studies collectively assessed the efficacy of a 3% trehalose and 0.15% hyaluronic acid eye drop solution in reducing postoperative eye symptoms compared to various control solutions. Parameters measured included tear break-up time (TBUT), Fluorescein staining, tear production (Schirmer test), and Ocular Surface Disease Index (OSDI) scores. The results indicated significant improvements in tear film stability and ocular surface health for the treatment groups compared to controls, with a notable decrease in patient-reported discomfort. The study showed an improvement of - 18 (± 14.6) in the treatment group compared to - 7 (± 8.0) in the control group for OSDI. For TBUT, the treatment group improved by 3 (± 1.2) s, whereas the control group improved by 0.3 (± 0.71) s. VA, measured on a scale of 0-100, increased to 17 (± 0.7) in the treatment group compared to 15 (± 1.1) in the control group.

CONCLUSIONS

Trehalose and hyaluronic acid may be beneficial in the postoperative period by enhancing tear film stability and ocular surface health. While the results are promising, further research is needed to confirm these findings, understand the mechanisms of action, and explore broader applications.

摘要

目的

本系统评价旨在评估海藻糖和透明质酸在白内障手术后眼部恢复中的疗效,重点关注它们对泪膜稳定性、眼表面完整性和患者报告结果的影响。

方法

通过 MEDLINE、PubMed 和 Cochrane Library 数据库全面检索,以评估海藻糖、透明质酸或两者联合在白内障手术后护理中的疗效的随机对照试验。纳入标准侧重于以英语发表的同行评议研究,详细描述与眼部恢复相关的结果,如泪膜稳定性、眼表面完整性、患者报告的不适或视力(VA)。使用 Cochrane 偏倚风险工具评估纳入研究的质量,并对数据进行定性综合。

结果

有 4 项定性研究符合纳入标准。这些研究共同评估了 3%海藻糖和 0.15%透明质酸滴眼液溶液与各种对照溶液相比,在减轻术后眼部症状方面的疗效。测量的参数包括泪膜破裂时间(TBUT)、荧光素染色、泪液产生(Schirmer 试验)和眼表面疾病指数(OSDI)评分。结果表明,与对照组相比,治疗组的泪膜稳定性和眼表面健康状况显著改善,患者报告的不适明显减轻。研究显示,治疗组的 OSDI 改善了-18(±14.6),而对照组改善了-7(±8.0)。对于 TBUT,治疗组改善了 3(±1.2)s,而对照组改善了 0.3(±0.71)s。VA 以 0-100 分衡量,治疗组增加到 17(±0.7),对照组增加到 15(±1.1)。

结论

海藻糖和透明质酸可通过增强泪膜稳定性和眼表面健康,在术后期间发挥有益作用。虽然结果很有希望,但需要进一步研究来证实这些发现,了解作用机制,并探索更广泛的应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验